Chromobacterium violaceum
(
C. violaceum
) is a Gram-negative, rod-shaped facultatively
anaerobic bacterium implicated with recalcitrant human infections.
Here, we evaluated the anti-QS and antibiofilm activities of ethyl
acetate extracts of
Passiflora edulis
(
P. edulis
) on the likely inactivation
of acyl-homoserine lactone (AHL)-regulated molecules in
C. violaceum
both by in vitro and in silico analyses.
Our investigations showed that the sub-MIC levels were 2, 1, and 0.5
mg/mL, and the concentrations showed a marked reduction in violacein
pigment production by 75.8, 64.6, and 35.2%. AHL quantification showed
72.5, 52.2, and 35.9% inhibitions, inhibitions of EPS production (72.8,
36.5, and 25.9%), and reductions in biofilm formation (90.7, 69.4,
and 51.8%) as compared to a control. Light microscopy and CLSM analysis
revealed dramatic reduction in the treated biofilm group as compared
to the control. GC–MS analysis showed 20 major peaks whose
chemical structures were docked as the CviR ligand. The highest docking
score was observed for hexadecanoic acid, 2-hydroxy-1-(hydroxymethyl)
ethyl ester bonds in the active site of CviR with a binding energy
of −8.825 kcal/mol. Together, we found that hexadecanoic acid,
2-hydroxy-1-(hydroxymethyl) ethyl ester remarkably interacted with
CviR to inhibit the QS system. Hence, we concluded that hexadecanoic
acid, 2-hydroxy-1-(hydroxymethyl) ethyl ester of
P.
edulis
could likely be evaluated for treating
C. violaceum
infections.